Protein drugs, recombinant vaccines and cell therapy are among the fastest growing products in the biotech industry. It is important to ensure quality and safety of emerging biopharmaceutical or cellular products in addition to their efficacy. The mission of our group is to offer a consolidated testing service with the following features: 1. Global quality standards: International Conference on Harmonization (ICH), United States Food and Drug Administration (FDA), European Medicines Agency (EMEA) etc. 2. GLP quality systems: Compliance with GLP (Taiwan, FDA & OECD); Audit by qualified QA personnel for critical steps and procedures during each study 3. Quick response and timely delivery 4. Availability of customization